Cav2.3 Protein (R Type Calcium Channel Alpha 1E) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Cav2.3 Protein (R Type Calcium Channel Alpha 1E) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
CACNA1E encodes the alpha-1E subunit of R-type voltage-gated calcium channels (Cav2.3).
Cav2.3 Protein (R Type Calcium Channel Alpha 1E) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Cav2.3 Protein (R Type Calcium Channel Alpha 1E) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. Voltage-gated calcium channels. Pharmacological Reviews. 2005. ↩︎